| Three Months Ended | |||||||
| (in millions USD) | March 31, 2023 | March 31, 2022 | |||||
| Cash flows from operating activities: | |||||||
| Net income | $ | 254 | $ | 178 | |||
| Depreciation and amortization | 343 | 408 | |||||
| Finance expense, net and other(1) | 7 | 9 | |||||
| Deferred income taxes | 22 | 19 | |||||
| Other non-cash operating activities | 27 | 42 | |||||
| Net change in working capital | (174 | ) | 189 | ||||
| Net cash provided by operating activities | $ | 479 | $ | 845 | |||
| Cash flows from investing activities: | |||||||
| Purchases of property, plant, equipment, and intangible assets | $ | (853 | ) | $ | (643 | ) | |
| Other investing activities | 267 | 4 | |||||
| Net cash used in investing activities | $ | (586 | ) | $ | (639 | ) | |
| Cash flows from financing activities: | |||||||
| Proceeds from issuance of equity instruments and other | $ | 37 | $ | — | |||
| Proceeds (repayment) of debt, net | (30 | ) | 107 | ||||
| Other financing activities | 3 | 11 | |||||
| Net cash provided by financing activities | $ | 10 | $ | 118 | |||
| Effect of exchange rate changes | 1 | 1 | |||||
| Net change in cash and cash equivalents | $ | (96 | ) | $ | 325 | ||
| Cash and cash equivalents at the beginning of the period | 2,352 | 2,939 | |||||
| Cash and cash equivalents at the end of the period | $ | 2,256 | $ | 3,264 | |||
| (1) Finance expense, net and other has been adjusted to include interest and taxes paid that were previously included in "Other non-cash operating activities." Prior period amounts have been adjusted accordingly. | |||||||
Unaudited Reconciliation of IFRS to Adjusted Non-IFRS
